Genomic and vaccine preclinical studies reveal a novel mouse-adapted Helicobacter pylori model for the hpEastAsia genotype in Southeast Asia

Journal of Medical Microbiology - Tập 73 Số 1 - 2024
Thị Kim Cúc Nguyễn1, Hoang Dang Khoa2, Thi Lan Phuong Nguyen3, Thu Thuy Pham1, Bao Ngoc Mach2, Thi Chinh Nguyen1, Thi Lan Pham1, Paidamoyo M. Katsande4, Huynh A. Hong4, Huu Thai Duong3, Anh N. Phan5, Simon M. Cutting4, Minh Thiet Vu2, Văn Duy Nguyễn1,5
1Institute of Biotechnology and Environment, Nha Trang University, 2 Nguyen Dinh Chieu Street, Khanh Hoa, Vietnam
2NTT Hi-Tech Institute, Nguyen Tat Thanh University, 300A Nguyen Tat Thanh, Ho Chi Minh City, Vietnam
3Institute of Vaccines and Biological Medicals (IVAC), 9 Pasteur Street, Nha Trang, Khanh Hoa, Vietnam
4Department of Biological Sciences, Royal Holloway University of London, Egham, Surrey TW20 0EX, UK
5School of Engineering, Newcastle University, Newcastle upon Tyne NE1 7RU, UK

Tóm tắt

Introduction. Helicobacter pylori infection is a major global health concern, linked to the development of various gastrointestinal diseases, including gastric cancer. To study the pathogenesis of H. pylori and develop effective intervention strategies, appropriate animal pathogen models that closely mimic human infection are essential.

Gap statement. This study focuses on the understudied hpEastAsia genotype in Southeast Asia, a region marked by a high H. pylori infection rate. No mouse-adapted model strains has been reported previously. Moreover, it recognizes the urgent requirement for vaccines in developing countries, where overuse of antimicrobials is fuelling the emergence of resistance.

Aim. This study aims to establish a novel mouse-adapted H. pylori model specific to the hpEastAsia genotype prevalent in Southeast Asia, focusing on comparative genomic and histopathological analysis of pathogens coupled with vaccine preclinical studies.

Methodology. We collected and sequenced the whole genome of clinical strains of H. pylori from infected patients in Vietnam and performed comparative genomic analyses of H. pylori strains in Southeast Asia. In parallel, we conducted preclinical studies to assess the pathogenicity of the mouse-adapted H. pylori strain and the protective effect of a new spore-vectored vaccine candidate on male Mlac:ICR mice and the host immune response in a female C57BL/6 mouse model.

Results. Genome sequencing and comparison revealed unique and common genetic signatures, antimicrobial resistance genes and virulence factors in strains HP22 and HP34; and supported clarithromycin-resistant HP34 as a representation of the hpEastAsia genotype in Vietnam and Southeast Asia. HP34-infected mice exhibited gastric inflammation, epithelial erosion and dysplastic changes that closely resembled the pathology observed in human H. pylori infection. Furthermore, comprehensive immunological characterization demonstrated a robust host immune response, including both mucosal and systemic immune responses. Oral vaccination with candidate vaccine formulations elicited a significant reduction in bacterial colonization in the model.

Conclusion. Our findings demonstrate the successful development of a novel mouse-adapted H. pylori model for the hpEastAsia genotype in Vietnam and Southeast Asia. Our research highlights the distinctive genotype and pathogenicity of clinical H. pylori strains in the region, laying the foundation for targeted interventions to address this global health burden.

Từ khóa


Tài liệu tham khảo

10.1016/S2214-109X(19)30488-7

10.1002/ijc.28999

10.3390/antibiotics12020191

10.1111/hel.12403

10.18632/oncotarget.25757

10.1007/s42770-021-00675-0

10.1126/science.1080857

10.1016/S2468-1253(19)30328-0

10.1186/1471-2180-11-104

10.1099/mgen.0.000676

10.3390/jcm11113141

10.1186/s13099-017-0161-5

10.1371/journal.pone.0043370

10.1007/978-1-0716-1302-3_14

10.1016/s1357-4310(99)01591-9

10.1111/hel.12997

10.1186/s12915-018-0550-3

10.1038/s41396-020-00758-0

10.1128/JB.00722-08

Harwood, 1990, Molecular Biological Methods for Bacillus, 1990, 1

Nicholson, 1990, Molecular Biological Methods for Bacillus, 391

Andrews, 2010, FastQC: A Quality Control Tool for High Throughput Sequence Data Available online

10.1093/bioinformatics/bty654

10.1093/bioinformatics/btu170

10.1093/bioinformatics/btab630

10.1371/journal.pcbi.1005595

10.1093/nar/gkw569

10.1371/journal.pcbi.1010998

10.1186/s13099-022-00488-y

10.3389/fmicb.2021.687259

10.22207/JPAM.17.3.21

10.1111/mmi.14123

10.1186/s13099-021-00452-2

10.1038/s41598-023-35527-4

10.1016/s0016-5085(97)70155-0

10.1046/j.1083-4389.2002.00071.x

10.1172/JCI11450

Fox, 2003, Helicobacter pylori-associated gastric cancer in INS-GAS mice is gender specific, Cancer Res, 63, 942

10.1016/s0016-5085(03)00406-2

10.1128/IAI.00801-19

10.3390/toxins8060182

10.1034/j.1600-0463.2003.1110410.x

10.1128/IAI.70.6.3073-3079.2002

10.1128/IAI.66.4.1349-1355.1998

10.1128/IAI.70.7.3529-3538.2002

10.1128/IAI.67.6.3040-3046.1999

10.1007/s10156-004-0353-z

10.1111/j.1365-2036.2004.01911.x

10.1016/s1286-4579(03)00123-0

10.1158/0008-5472.CAN-05-1802

10.1053/j.gastro.2005.07.056

10.1073/pnas.0711183105

10.1016/j.ccr.2008.10.011

10.1016/s0016-5085(00)70412-4

10.1111/j.1348-0421.2004.tb03474.x

10.1128/mBio.00613-12

10.1128/IAI.00312-12

10.1111/hel.12807

10.1002/path.1422

10.1111/apt.13497

2017, Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis, Geneva

10.1099/jmm.0.000404

10.1023/a:1010691216207

10.1128/IAI.01107-07

10.1016/0016-5085(90)91156-z

10.1038/s41598-019-47240-2

10.1128/IAI.01176-06

10.1128/JB.00749-09

10.1073/pnas.1211248110

10.1126/science.7886456

10.1074/jbc.M604574200

10.1128/JB.186.2.356-365.2004

10.1084/jem.188.12.2277

10.1128/IAI.66.6.2879-2886.1998

10.1016/j.cmi.2016.07.013